Following a text from Joe Rogan on ibogaine's benefits for opiate addiction, Trump texted back, "Do you want FDA approval?
President trying to bluff through international crisis, making contradictory statements on Iran's radical 10-point list of ...
A Rich Life is a fortnightly periodical founded by Claude Walker. It covers the most interesting developments in the arts, culture, global news, the environment, global politics and the global ...
Last time I covered the FY25 results here, I indicated that this didn’t seem like a one-year transition. Instead, it felt like a two-to-three-year adjustment period before the business could return to ...
Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 ...
This morning, radiology software company Pro Medicus (ASX: PME) reported its results for the first half of 2024, and in response, the share price has fallen around 11% from $108 to $95.70 at the time ...
This morning, Energy One (ASX: EOL) released its results for H1 FY 2026, reporting revenue growth of 21% to $34.8 million, and net profit after tax growth of 61% to $4m. Over 90% of the revenue is ...
Now, as bad as it seems, the above result was expected, and the market was well informed about it prior to these results, so I don’t think these numbers drove the share price decline from around $6 ...
I (Growthgauge here) have been following the turnaround of Kip McGrath Education Centres for a couple of years now, and you can find my earlier articles here. Below, I’ve sketched out the turnaround ...
This morning, medical imaging software provider Pro Medicus reported yet another set of record results with revenue up 32% to $213 million and profit after tax up 39% to just over $115 million. This ...
When I last covered IPD Group (ASX: IPG), I argued that the share price looked interesting at around $3.70, because I thought the market had overreacted to the disappointing earnings guidance for H1 ...
One of my friends suggested I take a look at Keypath Education (ASX: KED), this morning, because it had just reported its quarterly. I have done so, an placed the company on my watchlist, as a result.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results